As of 2024-12-13, the Relative Valuation of Sigilon Therapeutics, Inc. (SGTX) is (267.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.47 USD, the upside of Sigilon Therapeutics, Inc. based on Relative Valuation is -1291.1%.
The range of the Relative Valuation is (166.93) - (281.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 24.4x | 17.5x |
| Forward P/E multiples | 11.3x - 19.1x | 18.8x |
| Fair Price | (166.93) - (281.95) | (267.65) |
| Upside | -842.9% - -1354.8% | -1291.1% |
| Date | P/E |